Segall Bryant & Hamill’s Repligen RGEN Stock Holding History

Segall Bryant & Hamill’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.2M	Buy	169,811 +14,786	+10%	+$1.82M	0.27%	119
2026 Q1	$18.3M	Buy	155,025 +8,045	+5%	+$1.12M	0.26%	139
2025 Q4	$24.1M	Buy	146,980 +7,602	+5%	+$1.19M	0.33%	103
2025 Q3	$18.6M	Sell	139,378 -9,221	-6%	-$1.12M	0.25%	143
2025 Q2	$18.5M	Buy	148,599 +3,203	+2%	+$408K	0.26%	129
2025 Q1	$18.5M	Buy	145,396 +13,253	+10%	+$2.04M	0.28%	112
2024 Q4	$19M	Buy	+132,143	New	+$18.9M	0.26%	118
2021 Q2	–	Sell	-10,194	Closed	-$1.98M	–	817
2021 Q1	$1.98M	Buy	+10,194	New	+$2.09M	0.02%	473

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Segall Bryant & Hamill's RGEN Position: Q2 2026 in Review

Segall Bryant & Hamill increased its Repligen (RGEN) stake by 9.5% in Q2 2026, buying an estimated $1.82M and bringing the position to 169,811 shares worth $23.2M. The position accounts for 0.27% of the portfolio, ranked #119.

Segall Bryant & Hamill first reported a position in RGEN in Q1 2021 and has held it in 8 quarters since. The position peaked at $24.1M in Q4 2025. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

Segall Bryant & Hamill held 169,811 shares of Repligen worth $23.2M as of Q2 2026.
Segall Bryant & Hamill bought 14,786 Repligen shares in Q2 2026, an estimated $1.82M.
Repligen made up 0.27% of Segall Bryant & Hamill's portfolio in Q2 2026, its #119 holding.
Segall Bryant & Hamill first reported a position in Repligen in Q1 2021 and has held it in 8 quarters since.
Segall Bryant & Hamill's Repligen position peaked at $24.1M in Q4 2025.
482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.